MRNA logo Moderna +
Moderna
+

Moderna (MRNA) Stock Price History

Moderna's stock price is $198.88 as of September 25, 2026. Over the past 52 weeks, MRNA stock has traded between a low of $22.28 and a high of $202.67. The current share price is approximately 1.87% below its 52-week high and 792.64% above its 52-week low, providing context on where Moderna is trading within its range over the past year.

A stock price represents the current market value of one share of a company’s stock. It reflects the price buyers are willing to pay and sellers are willing to accept. Stock prices change throughout the trading day based on supply and demand, company performance, market conditions, investor sentiment, and broader economic factors.

...more

Stock Price

$198.3 B

FY, 2022

Market cap

$0 B

FY, 2022

Dividends

$0

FY, 2022

PE Ratio

$198.3 B

FY, 2022

Shares Outsanding

$198.3 B

FY, 2022

Market Capitalization

$198.3 B

FY, 2022

Moderna Stock Price

$198.88 +4.06 2.08%
NASDAQ · USD · Past 5 Years
Choose Events
  • 1W 23.49%
  • 1M 32.89%
  • 3M 195.64%
  • 6M 271.25%
  • YTD 574.40%
  • 1Y 712.09%
  • 2Y 212.51%
  • 5Y 51.36%
  • 10Y
    Get instant access to data,
    Sign up for free
  • ALL
    Get instant access to data,
    Sign up for free
Last Updated: Sep 26, 2026, 4:01 PM ET |

Current Price

$198.88

Today's Change %

2.08%

Volume

13.73 M

Market Cap

$78.76 B

P/E Ratio (TTM)

-

Earning Yield

-4.01%

50-Day Moving Avg.

$107.40

200-Day Moving Avg.

$63.40

Beta

0.90

Dividend & Yield (TTM)

-

Next Earnings Date

Nov 05, 2026

1Y Analyst Target

$115.70

Moderna Stock Performance vs. Competitors

Sign in to download table
Last Updated: Sep 26, 2026, 4:01 PM ET |

Moderna Stock Performance by Year

Last Updated: Sep 26, 2026, 4:01 PM ET |

Hypothetical $10,000 Investment Growth

  • Since Inception

  • Same Starting Date

  • Speed 1x

  • Speed 1.5x

  • Speed 2x

  • Speed 2.5x

Q3 2026
  • 1Y
  • 3Y
  • 5Y
  • 10Y
    Get instant access to data,
    Sign up for free
  • Since IPO
    Get instant access to data,
    Sign up for free
Last Updated: Sep 26, 2026, 4:01 PM ET |

Moderna Historical Stock Price Data: 2018-2026

Sign in to download table
Last Updated: Sep 26, 2026, 4:01 PM ET |
Last updated Sep 26, 2026, 4:01 PM ET
Data provided by Financial Modeling Prep
Original source Market-data feeds
Methodology Latest available trading price
Limitations Prices may be real-time, delayed or end-of-day depending on market-data coverage

Frequently Asked Questions

1. What is Moderna's current stock price?

Moderna stock is trading at $198.88 per share as of Sep 25, 2026, with today's trading range between $192.51 and $202.67.

2. What is Moderna's 52-week high and low?

Moderna's 52-week range is $22.28 to $202.67 as of Sep 25, 2026, showing the highest and lowest prices Moderna stock has traded at over the past year.

3. What is Moderna's current P/E ratio (TTM)?

Moderna's current P/E ratio (TTM) is about N/A as of Sep 26, 2026.

4. What is Moderna's market cap today?

Moderna's market cap is about $78.91 Billion as of Sep 26, 2026, based on its current stock price and shares outstanding.

5. What is Moderna's revenue (TTM)?

Moderna's revenue (TTM) is about $2.23 Billion as of Jun 30, 2026, based on the latest available trailing twelve-month financial data.

6. How much dividend does Moderna pay?

Moderna's latest quarterly dividend is N/A per share, or about N/A annually. Based on the current stock price, Moderna's dividend yield is roughly N/A as of Sep 26, 2026.

People Also Search For

Bullfincher is a “visual-first” business intelligence and research platform. We believe that behind every great company, there is a great story. At Bullfincher, we make story-telling a little easier using dynamic visuals, charts, and graphs.

explore
Discover
Subscribe to our Newsletter !

Don’t worry, we won’t spam you.

Disclaimers - All data and information is provided “as is” for informational purposes only and is not intended for trading purposes or financial, investment, tax, legal, accounting, or other advice. Please consult your broker or financial representative to verify pricing before executing any trade. Bullfincher is not an investment adviser, financial adviser, or a securities broker.None of the data and information constitutes investment advice nor an offering, recommendation, or solicitation by Bullfincher to buy, sell, or hold any security or financial product, and Bullfincher makes no representation (and has no opinion) regarding the advisability or suitability of any investment.

None of the data and information constitutes investment advice (whether general or customized). The financial products or operations referred to in such data and information may not be suitable for your investment profile and investment objectives or expectations. It is your responsibility to consider whether any financial product or operation is suitable foryou based on your interests, investment objectives, investment horizon, and risk appetite. Bullfincher shall not be liable for any damages arising from any operations or investments in financial products referred to within. Bullfincher does not recommend using the data and information provided as the only basis for making any investment decision.

Bullfincher 2026, All rights reserved